HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Abstract
IgA nephropathy, described in 1968 as IgA-IgG immune-complex disease, is an autoimmune disease. Galactose-deficient IgA1 is recognized by unique autoantibodies, resulting in the formation of pathogenic immune complexes that ultimately induce glomerular injury. Thus, formation of the galactose-deficient IgA1-containing immune complexes is a critical factor in the pathogenesis of IgA nephropathy. Studies of molecular defects of IgA1 can define new biomarkers specific for IgA nephropathy that can be developed into clinical assays to aid in the diagnosis, assessment of prognosis, and monitoring of disease progression.
AuthorsJan Novak, Bruce A Julian, Jiri Mestecky, Matthew B Renfrow
JournalSeminars in immunopathology (Semin Immunopathol) Vol. 34 Issue 3 Pg. 365-82 (May 2012) ISSN: 1863-2300 [Electronic] Germany
PMID22434325 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antigen-Antibody Complex
  • Autoantibodies
  • Immunoglobulin A
  • Polysaccharides
  • Galactose
Topics
  • Animals
  • Antigen-Antibody Complex (immunology)
  • Autoantibodies (immunology)
  • Galactose (analysis)
  • Glomerular Mesangium (immunology, metabolism, pathology)
  • Glomerulonephritis, IGA (immunology, pathology)
  • Glycosylation
  • Humans
  • Immunoglobulin A (chemistry, immunology, metabolism)
  • Kidney (immunology, pathology)
  • Polysaccharides (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: